Literature DB >> 6731679

Melioidosis in Far North Queensland. A clinical and epidemiological review of twenty cases.

R W Guard, F A Khafagi, M C Brigden, L R Ashdown.   

Abstract

During the last 4 years, 20 cases of clinical melioidosis were diagnosed in the geographical area between Tully and Thursday Island. Sixteen were diagnosed by culture of Pseudomonas pseudomallei, and four by positive serology with appropriate clinical features. Most cases occurred during or after a heavy wet season. All patients were adult, and males predominated. Farmers and stockmen represented predisposed populations due to their prolonged soil contact. Ten patients were white Australians, six were Aborigines and four were Torres Strait Islanders. Twelve cases were first diagnosed by positive blood culture and four by sputum culture. The primary site of infection was pulmonary in 14 cases, genitourinary tract in one case, subcutaneous tissues in one case, and joints in two cases. In cases of fulminating infection metastatic abscesses were commonly found in many organs; typically lungs, liver, kidneys and spleen. Six patients had acute fulminating disease and died. Fourteen patients successfully responded to appropriate therapy, but relapse occurred in three, all of whom had an alcohol problem and showed poor drug compliance. The presence of diabetes mellitus in six patients confirmed the important known association of these two diseases. In three fulminating and four subacute infections the serology was negative at the time of diagnosis by culture. Antibiotic therapy for the different forms of this disease is reviewed, and a laboratory protocol for the rapid reporting of positive culture results is included.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6731679     DOI: 10.4269/ajtmh.1984.33.467

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  Effects of soil pH, temperature and water content on the growth of Burkholderia pseudomallei.

Authors:  Y S Chen; S C Chen; C M Kao; Y L Chen
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei.

Authors:  K Miyagi; K Kawakami; A Saito
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

3.  Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis.

Authors:  M Sookpranee; P Boonma; W Susaengrat; K Bhuripanyo; S Punyagupta
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

4.  Evaluation of Culture Techniques for Isolation of Pseudomonas pseudomallei from Soil.

Authors:  L R Ashdown; S G Clarke
Journal:  Appl Environ Microbiol       Date:  1992-12       Impact factor: 4.792

5.  Evaluation of a new commercially available immunoglobulin M and immunoglobulin G immunochromatographic test for diagnosis of melioidosis infection.

Authors:  A J Cuzzubbo; V Chenthamarakshan; J Vadivelu; S D Puthucheary; D Rowland; P L Devine
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

6.  In vitro activities of the newer beta-lactam and quinolone antimicrobial agents against Pseudomonas pseudomallei.

Authors:  L R Ashdown
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

7.  Neurologic melioidosis.

Authors:  Martin Deuble; Chloe Aquilina; Robert Norton
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

Review 8.  Melioidosis: the tip of the iceberg?

Authors:  D A Dance
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

9.  Outcomes of patients with melioidosis treated with meropenem.

Authors:  Allen C Cheng; Dale A Fisher; Nicholas M Anstey; Dianne P Stephens; Susan P Jacups; Bart J Currie
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

10.  Musculoskeletal melioidosis: clinical and imaging features.

Authors:  M H Pui; A P Tan
Journal:  Skeletal Radiol       Date:  1995-10       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.